Portage Biotech Inc (PRTG)
$3.15
+0.31
(+10.92%)▲
Market is closed - opens 7 PM, 11 Sep 2024
Performance
- $2.83$3.42$3.15
10.16%
Downside
Day's Volatility :17.25%
Upside
7.89%
- $2.10$60.42$3.15
33.4%
Downside
52 Weeks Volatility :96.53%
Upside
94.79%
Returns
| Period | Portage Biotech Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -47.53% | 4.7% | 0.0% |
6 Months | -72.13% | 5.1% | 0.0% |
1 Year | -94.48% | 16.6% | 0.0% |
3 Years | -99.21% | 15.6% | -20.6% |
Highlights
Market Capitalization | 3.1M |
Book Value | $2.39 |
Earnings Per Share (EPS) | 24.4 |
PE Ratio | 0.12 |
Wall Street Target Price | 7.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -19.42% |
Return On Equity TTM | -191.03% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -16.0M |
Diluted Eps TTM | 24.4 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.65 |
EPS Estimate Next Year | -0.52 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Sell
0
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Portage Biotech Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
- Current
- 1M Ago
- 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
3
3
3
Analyst Forecast
What analysts predicted
Upside of 122.22%
Current $3.15
Target $7.00
Technicals Summary
Sell
Neutral
Buy
Portage Biotech Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Portage Biotech Inc | -1.2% | -72.13% | -94.48% | -99.21% | -99.59% |
 Regeneron Pharmaceuticals, Inc. | 0.93% | 17.32% | 35.75% | 73.95% | 298.81% |
 Novo Nordisk A/s | 0.96% | -0.08% | 31.44% | 163.47% | 428.79% |
 Alnylam Pharmaceuticals, Inc. | -8.66% | 65.51% | 21.14% | 30.19% | 192.84% |
 Vertex Pharmaceuticals Incorporated | 0.75% | 12.92% | 34.78% | 148.18% | 173.67% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Portage Biotech Inc | 0.12 | 0.12 | NA | -0.65 | -1.91 | -0.19 | NA | 2.39 |
Regeneron Pharmaceuticals, Inc. | 29.93 | 29.93 | 1.54 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 44.01 | 44.01 | 1.98 | 3.44 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.57 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Portage Biotech Inc | Sell | $3.1M | -99.59% | 0.12 | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $124.7B | 298.81% | 29.93 | 32.04% |
Novo Nordisk A/s | Buy | $585.3B | 428.79% | 44.01 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $32.3B | 192.84% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $120.9B | 173.67% | 32.84 | -4.74% |
Insights on Portage Biotech Inc
Vs VRTX
In the last 1 year, Vertex Pharmaceuticals Incorporated has given 36.4% return, outperforming this stock by 130.8%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 148.2% return, outperforming this stock by 247.4%
Institutional Holdings
Armistice Capital, LLC
7.16%Lakeview Capital Partners, LLC
1.02%PEAK6 INVESTMENTS LP
0.26%Renaissance Technologies Corp
0.15%IEQ CAPITAL, LLC
0.08%XTX Topco Ltd
0.08%
Company Information
portage biotech inc is a company based out of canada.
Organization | Portage Biotech Inc |
Employees | 7 |
CEO | Dr. Ian B. Walters M.B.A., M.D. |
Industry | Healthcare |
